{"count": 8, "results": [{"_id": "36170869", "pmid": 36170869, "title": "Metformin is Protective Against the Development of Mood Disorders.", "journal": "Pharmacopsychiatry", "authors": ["Lake J", "Bortolasci CC", "Stuart AL", "Pasco JA", "Kidnapillai S", "Spolding B", "Truong TTT", "Panizzutti B", "Liu ZSJ", "Dean OM", "Crowley T", "Richardson M", "Kim JH", "Berk M", "Williams LJ", "Walder K"], "date": "2023-01-01T00:00:00Z", "doi": "10.1055/a-1936-3580", "meta_date_publication": "2023 Jan", "meta_volume": "56", "meta_issue": "1", "meta_pages": "25-31", "score": 50280.742, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is Protective Against the Development of @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@Mood Disorders@@@.", "citations": {"NLM": "Lake J, Bortolasci CC, Stuart AL, Pasco JA, Kidnapillai S, Spolding B, Truong TTT, Panizzutti B, Liu ZSJ, Dean OM, Crowley T, Richardson M, Kim JH, Berk M, Williams LJ, Walder K. Metformin is Protective Against the Development of Mood Disorders. Pharmacopsychiatry. 2023 Jan;56(1):25-31. PMID: 36170869", "BibTeX": "@article{36170869, title={Metformin is Protective Against the Development of Mood Disorders.}, author={Lake J and Bortolasci CC and Stuart AL and Pasco JA and Kidnapillai S and Spolding B and Truong TTT and Panizzutti B and Liu ZSJ and Dean OM and Crowley T and Richardson M and Kim JH and Berk M and Williams LJ and Walder K}, journal={Pharmacopsychiatry}, volume={56}, number={1}, pages={25-31}}"}}, {"_id": "36810174", "pmid": 36810174, "pmcid": "PMC9945047", "title": "Double-blind, randomised placebo-controlled clinical trial of metformin as an adjunct to a sleep-wake, activity and metabolically focused behavioural intervention to improve cardiometabolic outcomes and mood symptoms in youth with major mood syndromes: study protocol", "journal": "BMJ Open", "authors": ["Wilson C", "Carpenter JS", "Nichles A", "Zmicerevska N", "Song YJC", "McHugh C", "Hamilton B", "Hockey S", "Crouse J", "Koethe D", "Scott EM", "Hickie IB"], "date": "2023-02-21T00:00:00Z", "doi": "10.1136/bmjopen-2022-064682", "meta_date_publication": "2023 Feb 21", "meta_volume": "13", "meta_issue": "2", "meta_pages": "e064682", "score": 50259.703, "text_hl": "Double-blind, randomised placebo-controlled clinical trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an adjunct to a sleep-wake, activity and metabolically focused behavioural intervention to improve cardiometabolic outcomes and @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@mood symptoms@@@ in youth with major @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@mood syndromes@@@: study protocol", "citations": {"NLM": "Wilson C, Carpenter JS, Nichles A, Zmicerevska N, Song YJC, McHugh C, Hamilton B, Hockey S, Crouse J, Koethe D, Scott EM, Hickie IB. Double-blind, randomised placebo-controlled clinical trial of metformin as an adjunct to a sleep-wake, activity and metabolically focused behavioural intervention to improve cardiometabolic outcomes and mood symptoms in youth with major mood syndromes: study protocol BMJ Open. 2023 Feb 21;13(2):e064682. PMID: 36810174", "BibTeX": "@article{36810174, title={Double-blind, randomised placebo-controlled clinical trial of metformin as an adjunct to a sleep-wake, activity and metabolically focused behavioural intervention to improve cardiometabolic outcomes and mood symptoms in youth with major mood syndromes: study protocol}, author={Wilson C and Carpenter JS and Nichles A and Zmicerevska N and Song YJC and McHugh C and Hamilton B and Hockey S and Crouse J and Koethe D and Scott EM and Hickie IB}, journal={BMJ Open}, volume={13}, number={2}, pages={e064682}}"}}, {"_id": "40403856", "pmid": 40403856, "title": "Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression.", "journal": "Neurosci Biobehav Rev", "authors": ["Yao J", "Zhu CQ", "Sun Y", "Huang YW", "Li QH", "Liao HM", "Deng XJ", "Li WM"], "date": "2025-05-20T00:00:00Z", "doi": "10.1016/j.neubiorev.2025.106218", "meta_date_publication": "2025 May 20", "meta_volume": "175", "meta_issue": "", "meta_pages": "106218", "score": 50224.902, "text_hl": "Concurrently, certain antidiabetic agents show promise in managing @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @GENE_SLC5A2 @GENE_6524 @@@sodium-glucose cotransporter-2@@@ inhibitors may be prioritized for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ at risk for @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@, while @GENE_GLP1R @GENE_2740 @@@glucagon-like peptide-1 receptor@@@ agonists appear particularly beneficial for @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@-related @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@mood disturbances@@@. ", "citations": {"NLM": "Yao J, Zhu CQ, Sun Y, Huang YW, Li QH, Liao HM, Deng XJ, Li WM. Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression. Neurosci Biobehav Rev. 2025 May 20;175():106218. PMID: 40403856", "BibTeX": "@article{40403856, title={Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression.}, author={Yao J and Zhu CQ and Sun Y and Huang YW and Li QH and Liao HM and Deng XJ and Li WM}, journal={Neurosci Biobehav Rev}, volume={175}, pages={106218}}"}}, {"_id": "23194378", "pmid": 23194378, "pmcid": "PMC3529194", "title": "Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study", "journal": "BMC Med", "authors": ["Wahlqvist ML", "Lee MS", "Chuang SY", "Hsu CC", "Tsai HN", "Yu SH", "Chang HY"], "date": "2012-11-29T00:00:00Z", "doi": "10.1186/1741-7015-10-150", "meta_date_publication": "2012 Nov 29", "meta_volume": "10", "meta_issue": "", "meta_pages": "150", "score": 50075.9, "text_hl": "Neither @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@ nor @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone were associated with a significant change in @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@AD@@@ incidence. ", "citations": {"NLM": "Wahlqvist ML, Lee MS, Chuang SY, Hsu CC, Tsai HN, Yu SH, Chang HY. Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study BMC Med. 2012 Nov 29;10():150. PMID: 23194378", "BibTeX": "@article{23194378, title={Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study}, author={Wahlqvist ML and Lee MS and Chuang SY and Hsu CC and Tsai HN and Yu SH and Chang HY}, journal={BMC Med}, volume={10}, pages={150}}"}}, {"_id": "25373124", "pmid": 25373124, "title": "Metformin for weight loss and control in patients with mood disorder.", "journal": "J Clin Psychiatry", "authors": ["Linneke JL", "Jørgensen GK", "Csillag C"], "date": "2014-10-01T00:00:00Z", "doi": "10.4088/JCP.14cr09133", "meta_date_publication": "2014 Oct", "meta_volume": "75", "meta_issue": "10", "meta_pages": "e1140-1", "score": 50068.11, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ and control in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@mood disorder@@@.", "citations": {"NLM": "Linneke JL, Jørgensen GK, Csillag C. Metformin for weight loss and control in patients with mood disorder. J Clin Psychiatry. 2014 Oct;75(10):e1140-1. PMID: 25373124", "BibTeX": "@article{25373124, title={Metformin for weight loss and control in patients with mood disorder.}, author={Linneke JL and Jørgensen GK and Csillag C}, journal={J Clin Psychiatry}, volume={75}, number={10}, pages={e1140-1}}"}}, {"_id": "30182764", "pmid": 30182764, "title": "A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome.", "journal": "Gynecol Endocrinol", "authors": ["Erensoy H", "Niafar M", "Ghafarzadeh S", "Aghamohammadzadeh N", "Nader ND"], "date": "2019-01-01T00:00:00Z", "doi": "10.1080/09513590.2018.1498476", "meta_date_publication": "2019 Jan", "meta_volume": "35", "meta_issue": "1", "meta_pages": "72-75", "score": 50055.184, "text_hl": "A pilot trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ and @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@mood disturbances@@@ in adolescent and adult @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@.", "citations": {"NLM": "Erensoy H, Niafar M, Ghafarzadeh S, Aghamohammadzadeh N, Nader ND. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome. Gynecol Endocrinol. 2019 Jan;35(1):72-75. PMID: 30182764", "BibTeX": "@article{30182764, title={A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome.}, author={Erensoy H and Niafar M and Ghafarzadeh S and Aghamohammadzadeh N and Nader ND}, journal={Gynecol Endocrinol}, volume={35}, number={1}, pages={72-75}}"}}, {"_id": "23938069", "pmid": 23938069, "title": "A \"glucose eater\" drug as a therapeutic agent in psychiatry.", "journal": "J Psychosoc Nurs Ment Health Serv", "authors": ["Howland RH"], "date": "2013-09-01T00:00:00Z", "doi": "10.3928/02793695-20130805-01", "meta_date_publication": "2013 Sep", "meta_volume": "51", "meta_issue": "9", "meta_pages": "13-6", "score": 50044.305, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has the potential effect of inducing hippocampal neurogenesis, and additional studies of this drug are warranted in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@mood or cognitive disorders@@@.", "citations": {"NLM": "Howland RH. A \"glucose eater\" drug as a therapeutic agent in psychiatry. J Psychosoc Nurs Ment Health Serv. 2013 Sep;51(9):13-6. PMID: 23938069", "BibTeX": "@article{23938069, title={A \"glucose eater\" drug as a therapeutic agent in psychiatry.}, author={Howland RH}, journal={J Psychosoc Nurs Ment Health Serv}, volume={51}, number={9}, pages={13-6}}"}}, {"_id": "23194414", "pmid": 23194414, "pmcid": "PMC3566919", "title": "Pathways to new drug discovery in neuropsychiatry", "journal": "BMC Med", "authors": ["Berk M"], "date": "2012-11-29T00:00:00Z", "doi": "10.1186/1741-7015-10-151", "meta_date_publication": "2012 Nov 29", "meta_volume": "10", "meta_issue": "", "meta_pages": "151", "score": 50034.348, "text_hl": "Serendipitous discoveries, based on astute clinical observation or data mining, remain a valid option, as is illustrated by the suggestion in the paper by Wahlqvist and colleagues that treatment with @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces the risk of @<m>DISEASE_Mood_Disorders</m> @DISEASE_MESH:D019964 @@@affective disorder@@@. ", "citations": {"NLM": "Berk M. Pathways to new drug discovery in neuropsychiatry BMC Med. 2012 Nov 29;10():151. PMID: 23194414", "BibTeX": "@article{23194414, title={Pathways to new drug discovery in neuropsychiatry}, author={Berk M}, journal={BMC Med}, volume={10}, pages={151}}"}}]}